Close
ACHEMA MIDDLE EAST 2026

New Pharma Legislation – Ambitious And Forward-Looking

It is worth noting that political decision-makers at present happen to be under pressure to swiftly accomplish the initial reading of the European Union's...

Korean & British Advanced Biotech To Cement Tech Partnership

During South Korean President Yoon Suk Yeol's state visit to the UK, several MoUs were signed between major universities as well as research institutes...

Pharma Spectrum – Using Connected Drug Delivery Devices

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more...

NPRA In Malaysia Has Broadened Reference Approval Guidelines

The National Pharmaceutical Regulatory Agency- NPRA of Malaysia has recently gone on to revise its guidelines with regards to the approval pathways for medicines that...

Pharmaceutical Packaging – Finding Its Way Beyond Borders

According to a study that was conducted by Grand View Research 1, the global pharmaceutical packaging market is all set to grow at a...

New Pharma Legislation May Affect Europe R&D Significantly

The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a...

Vetter In Rankweil Gets Permanent Manufacturer Authorization

Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...